SECOND OPINION: PFIZER’S PHONY CALL FOR LOWER DRUG COSTS
Jun 22, 2021
CEO Sidesteps Big Pharma’s Pricing Practices; Pushes Proposals That Would… Read More
© 2024 CSRXP- All Rights Reserved
Blog Posts
WHAT THEY ARE SAYING: BIOGEN’S “SIMPLY UNACCEPTABLE” ADUCANUMAB PRICING HIGHLIGHTS URGENCY FOR RX SOLUTIONS
Jun 14, 2021
Broad-based Opposition to Egregious Launch Price on Drug With Unproven… Read More
SECOND OPINION: DEBUNKING BIG PHARMA’S BOGUS INNOVATION RHETORIC
Jun 7, 2021
For far too long Big Pharma has used the excuse that research and development… Read More
THEY SAID IT! ABBVIE CEO BRAGS ON ABILITY TO HIKE PRICES IN U.S., ADMITS COMPETITION WORKS AND CONFIRMS BIG PHARMA PATENT GAMES DESIGNED FOR “PRICING POWER”
May 19, 2021
House Oversight Lawmakers Commit to Bipartisan Action to Hold Big Pharma… Read More
DOSE OF REALITY: HUMIRA: A CASE STUDY IN BIG PHARMA GREED
May 17, 2021
AbbVie CEO Headed for Capitol Hill to Answer for Indefensible Anti-Competitive… Read More
THEY SAID IT! LAWMAKERS CALL FOR BIPARTISAN ACTION TO LOWER RX PRICES IN PAIR OF HOUSE HEARINGS
May 5, 2021
Members of Congress in Both Parties Recognize Urgency for Solutions to Deliver… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE & ASTRAZENECA
May 5, 2021
Drug Companies Top Wall Street Expectations; Pfizer Raises Guidance Based On… Read More
BIG PHARMA EARNINGS WATCH: SANOFI, MERCK, BRISTOL-MYERS SQUIBB, AMGEN & GLAXOSMITHKLINE
May 4, 2021
Brand Name Drug Makers Boosting Profits, Sales After Engaging In Pandemic… Read More
BIG PHARMA WATCH: GAO REPORT FINDS U.S. CONSUMERS PAY DOUBLE TO QUADRUPLE FOR RX DRUGS
Apr 29, 2021
Study Finds Americans Face Much Higher Drug Prices Than Patients In Other… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS, ELI LILLY & ROCHE
Apr 29, 2021
Trio of Big Pharma Firms Bank Q1 Profits Driven By Price Hikes New first… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 20, 2021
Drug Company Banks Expectation-Busting Profits for Q1 While Continuing to Hike… Read More
DOSE OF REALITY: BIG PHARMA’S PRICING PRACTICES DRIVE CRISIS OF AFFORDABILITY FOR AMERICA’S CANCER PATIENTS
Apr 15, 2021
Drug Companies Repeatedly Hike Prices and Set Out-of-Control Launch Prices on… Read More